BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 20955143)

  • 21. Iontophoretic drug delivery across the nail.
    Delgado-Charro MB
    Expert Opin Drug Deliv; 2012 Jan; 9(1):91-103. PubMed ID: 22149385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Iontophoresis across the proximal nail fold to target drugs to the nail matrix.
    Manda P; Sammeta SM; Repka MA; Murthy SN
    J Pharm Sci; 2012 Jul; 101(7):2392-7. PubMed ID: 22487899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Iontophoresis to Overcome the Challenge of Nail Permeation: Considerations and Optimizations for Successful Ungual Drug Delivery.
    Chen K; Puri V; Michniak-Kohn B
    AAPS J; 2021 Jan; 23(1):25. PubMed ID: 33439400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Terbinafine hydrochloride loaded liposome film formulation for treatment of onychomycosis: in vitro and in vivo evaluation.
    Tanrıverdi ST; Hilmioğlu Polat S; Yeşim Metin D; Kandiloğlu G; Özer Ö
    J Liposome Res; 2016; 26(2):163-73. PubMed ID: 26226352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of a novel penetration enhancer on the ungual permeation of two antifungal agents.
    Traynor MJ; Turner RB; Evans CR; Khengar RH; Jones SA; Brown MB
    J Pharm Pharmacol; 2010 Jun; 62(6):730-7. PubMed ID: 20636860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Iontophoretic drug delivery across human nail.
    Narasimha Murthy S; Wiskirchen DE; Bowers CP
    J Pharm Sci; 2007 Feb; 96(2):305-11. PubMed ID: 17080425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A preformulation strategy for the selection of penetration enhancers for a transungual formulation.
    Palliyil B; Lebo DB; Patel PR
    AAPS PharmSciTech; 2013 Jun; 14(2):682-91. PubMed ID: 23572254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ungual and transungual drug delivery.
    Shivakumar HN; Juluri A; Desai BG; Murthy SN
    Drug Dev Ind Pharm; 2012 Aug; 38(8):901-11. PubMed ID: 22149347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancing the nail permeability of topically applied drugs.
    Murdan S
    Expert Opin Drug Deliv; 2008 Nov; 5(11):1267-82. PubMed ID: 18976136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trans-ungual delivery of itraconazole hydrochloride by iontophoresis.
    Kushwaha A; Jacob M; Shiva Kumar HN; Hiremath S; Aradhya S; Repka MA; Murthy SN
    Drug Dev Ind Pharm; 2015; 41(7):1089-94. PubMed ID: 25482587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Constant Voltage Iontophoresis Technique to Deliver Terbinafine via Transungual Delivery System: Formulation Optimization Using Box-Behnken Design and In Vitro Evaluation.
    Nair AB; Al-Dhubiab BE; Shah J; Gorain B; Jacob S; Attimarad M; Sreeharsha N; Venugopala KN; Morsy MA
    Pharmaceutics; 2021 Oct; 13(10):. PubMed ID: 34683985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. UV-curable gel formulations: Potential drug carriers for the topical treatment of nail diseases.
    Kerai LV; Hilton S; Murdan S
    Int J Pharm; 2015 Aug; 492(1-2):177-90. PubMed ID: 26187167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Iontophoretically enhanced ciclopirox delivery into and across human nail plate.
    Hao J; Smith KA; Li SK
    J Pharm Sci; 2009 Oct; 98(10):3608-16. PubMed ID: 19117048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An investigation of how fungal infection influences drug penetration through onychomycosis patient's nail plates.
    McAuley WJ; Jones SA; Traynor MJ; Guesné S; Murdan S; Brown MB
    Eur J Pharm Biopharm; 2016 May; 102():178-84. PubMed ID: 26969264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bilayered nail lacquer of terbinafine hydrochloride for treatment of onychomycosis.
    Shivakumar HN; Vaka SR; Madhav NV; Chandra H; Murthy SN
    J Pharm Sci; 2010 Oct; 99(10):4267-76. PubMed ID: 20737634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Formulation development and optimization of transungual drug delivery system of terbinafine hydrochloride for the treatment of onychomycosis.
    Patel MM; Vora ZM
    Drug Deliv Transl Res; 2016 Jun; 6(3):263-75. PubMed ID: 26926242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transdermal iontophoretic delivery of terbinafine hydrochloride: quantitation of drug levels in stratum corneum and underlying skin.
    Sachdeva V; Siddoju S; Yu YY; Kim HD; Friden PM; Banga AK
    Int J Pharm; 2010 Mar; 388(1-2):24-31. PubMed ID: 20025950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Iontophoretic terbinafine delivery in onychomycosis: questionable nail growth.
    Oon HH; Tan HH
    Br J Dermatol; 2010 Mar; 162(3):699-700. PubMed ID: 20030642
    [No Abstract]   [Full Text] [Related]  

  • 39. Hydration of nail plate: a novel screening model for transungual drug permeation enhancers.
    Chouhan P; Saini TR
    Int J Pharm; 2012 Oct; 436(1-2):179-82. PubMed ID: 22705091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ciclopirox delivery into the human nail plate.
    Hui X; Wester RC; Barbadillo S; Lee C; Patel B; Wortzmman M; Gans EH; Maibach HI
    J Pharm Sci; 2004 Oct; 93(10):2545-8. PubMed ID: 15349963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.